Oncotarget:丹参根中的天然化合物“隐丹参酮”对肾细胞癌有显著的抑制作用!

2017-08-23 Emma MedSci原创

肾细胞癌(简称肾癌)是泌尿系统中恶性度较高的肿瘤,也是最常见的肿瘤之一,是起源于肾实质泌尿小管上皮系统的恶性肿瘤,又称肾腺癌。

肾细胞癌(简称肾癌)是泌尿系统中恶性度较高的肿瘤,也是最常见的肿瘤之一,是起源于肾实质泌尿小管上皮系统的恶性肿瘤,又称肾腺癌。男女发病率有明显差异,据统计,男女之比为2:1。肾癌的发病率随年龄增大而升高,有资料显示,肾癌的高发年龄在40~55岁。信号转导和转录激活因子3(STAT3)是转录因子,在控制细胞生长、存活、血管生成和免疫功能中起重要作用,也是人类癌症中最常激活的STAT家族成员之一。

有研究报道,STAT3在不同类型的肾细胞癌(RCC)中被持续激活,并且可以作为预后标记, STAT3抑制剂WP1066,能够对RCC细胞系和异种移植小鼠模型发挥抗癌作用。Cryptotanshinone(隐丹参酮),是从丹参根中提取的天然化合物,被认为是潜在的STAT3抑制剂。因此研究人员探究了隐丹参酮在RCC的中的作用及作用方式。

结果显示隐丹参酮可显著抑制癌细胞生长,同时通过抑制Tyr705上STAT3的磷酸化及阻断核易位来促进癌细胞凋亡,并且p-Akt、CyclinD1、c-myc、MEKK2,HGF表达下调,细胞周期被阻滞于G0/G1期,从而抑制癌细胞增殖。此外,cleaved-Caspase-3的水平升高,而Bcl-2和Survivin下调,导致细胞凋亡增加。体内试验研究结果显示,隐丹参酮在A498异种移植小鼠模型中能够有效抑制肿瘤发生。

该研究结果阐明了隐丹参酮在RCC中的功能,并展现了应用隐丹参酮作为RCC治疗策略的强大潜力。

原始出处:
Chen Z, et al. Cryptotanshinone inhibits proliferation yet induces apoptosis by suppressing STAT3 signals in renal cell carcinoma. Oncotarget. 2017 Jul 25;8(30):50023-50033. doi: 10.18632/oncotarget.18483.

本文系梅斯医学(MedSci)原创翻译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1978545, encodeId=82d319e85459b, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Jul 25 06:50:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795450, encodeId=a18e1e9545044, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Oct 07 13:50:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635431, encodeId=827e163543136, content=<a href='/topic/show?id=b099549160a' target=_blank style='color:#2F92EE;'>#抑制作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54916, encryptionId=b099549160a, topicName=抑制作用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd322475383, createdName=124987a0m73(暂无昵称), createdTime=Wed Nov 15 23:50:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906359, encodeId=e0091906359db, content=<a href='/topic/show?id=7795334e220' target=_blank style='color:#2F92EE;'>#化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33472, encryptionId=7795334e220, topicName=化合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Sat Jul 07 11:50:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538674, encodeId=07c715386e492, content=<a href='/topic/show?id=59c044154e0' target=_blank style='color:#2F92EE;'>#天然化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44154, encryptionId=59c044154e0, topicName=天然化合物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfa413003642, createdName=TZF0808, createdTime=Fri Aug 25 05:50:00 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236785, encodeId=fc15236e859c, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Aug 24 22:24:54 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236636, encodeId=d34223663661, content=中药单体抗肿瘤又一杰作, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/05/df5ba40a3e218ebaa92f792a589d4bc6.jpg, createdBy=b5081439740, createdName=nkyanglei, createdTime=Thu Aug 24 10:32:51 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236416, encodeId=036623641658, content=已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4ib9DvJ86XtOw5PH8FicmNC2SQbYVgLXBxVWA2A4LlibcSyK7bCJHLVdX00iah2aM0XTEZ7SKtLb3ANw/0, createdBy=006d1709280, createdName=1de9c4fdm02(暂无匿称), createdTime=Wed Aug 23 17:43:48 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236385, encodeId=ae9723638565, content=肾细胞癌治疗又一法宝., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Aug 23 15:54:35 CST 2017, time=2017-08-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1978545, encodeId=82d319e85459b, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Jul 25 06:50:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795450, encodeId=a18e1e9545044, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Oct 07 13:50:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635431, encodeId=827e163543136, content=<a href='/topic/show?id=b099549160a' target=_blank style='color:#2F92EE;'>#抑制作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54916, encryptionId=b099549160a, topicName=抑制作用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd322475383, createdName=124987a0m73(暂无昵称), createdTime=Wed Nov 15 23:50:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906359, encodeId=e0091906359db, content=<a href='/topic/show?id=7795334e220' target=_blank style='color:#2F92EE;'>#化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33472, encryptionId=7795334e220, topicName=化合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Sat Jul 07 11:50:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538674, encodeId=07c715386e492, content=<a href='/topic/show?id=59c044154e0' target=_blank style='color:#2F92EE;'>#天然化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44154, encryptionId=59c044154e0, topicName=天然化合物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfa413003642, createdName=TZF0808, createdTime=Fri Aug 25 05:50:00 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236785, encodeId=fc15236e859c, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Aug 24 22:24:54 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236636, encodeId=d34223663661, content=中药单体抗肿瘤又一杰作, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/05/df5ba40a3e218ebaa92f792a589d4bc6.jpg, createdBy=b5081439740, createdName=nkyanglei, createdTime=Thu Aug 24 10:32:51 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236416, encodeId=036623641658, content=已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4ib9DvJ86XtOw5PH8FicmNC2SQbYVgLXBxVWA2A4LlibcSyK7bCJHLVdX00iah2aM0XTEZ7SKtLb3ANw/0, createdBy=006d1709280, createdName=1de9c4fdm02(暂无匿称), createdTime=Wed Aug 23 17:43:48 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236385, encodeId=ae9723638565, content=肾细胞癌治疗又一法宝., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Aug 23 15:54:35 CST 2017, time=2017-08-23, status=1, ipAttribution=)]
    2017-10-07 仁医06
  3. [GetPortalCommentsPageByObjectIdResponse(id=1978545, encodeId=82d319e85459b, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Jul 25 06:50:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795450, encodeId=a18e1e9545044, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Oct 07 13:50:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635431, encodeId=827e163543136, content=<a href='/topic/show?id=b099549160a' target=_blank style='color:#2F92EE;'>#抑制作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54916, encryptionId=b099549160a, topicName=抑制作用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd322475383, createdName=124987a0m73(暂无昵称), createdTime=Wed Nov 15 23:50:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906359, encodeId=e0091906359db, content=<a href='/topic/show?id=7795334e220' target=_blank style='color:#2F92EE;'>#化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33472, encryptionId=7795334e220, topicName=化合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Sat Jul 07 11:50:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538674, encodeId=07c715386e492, content=<a href='/topic/show?id=59c044154e0' target=_blank style='color:#2F92EE;'>#天然化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44154, encryptionId=59c044154e0, topicName=天然化合物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfa413003642, createdName=TZF0808, createdTime=Fri Aug 25 05:50:00 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236785, encodeId=fc15236e859c, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Aug 24 22:24:54 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236636, encodeId=d34223663661, content=中药单体抗肿瘤又一杰作, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/05/df5ba40a3e218ebaa92f792a589d4bc6.jpg, createdBy=b5081439740, createdName=nkyanglei, createdTime=Thu Aug 24 10:32:51 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236416, encodeId=036623641658, content=已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4ib9DvJ86XtOw5PH8FicmNC2SQbYVgLXBxVWA2A4LlibcSyK7bCJHLVdX00iah2aM0XTEZ7SKtLb3ANw/0, createdBy=006d1709280, createdName=1de9c4fdm02(暂无匿称), createdTime=Wed Aug 23 17:43:48 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236385, encodeId=ae9723638565, content=肾细胞癌治疗又一法宝., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Aug 23 15:54:35 CST 2017, time=2017-08-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1978545, encodeId=82d319e85459b, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Jul 25 06:50:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795450, encodeId=a18e1e9545044, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Oct 07 13:50:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635431, encodeId=827e163543136, content=<a href='/topic/show?id=b099549160a' target=_blank style='color:#2F92EE;'>#抑制作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54916, encryptionId=b099549160a, topicName=抑制作用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd322475383, createdName=124987a0m73(暂无昵称), createdTime=Wed Nov 15 23:50:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906359, encodeId=e0091906359db, content=<a href='/topic/show?id=7795334e220' target=_blank style='color:#2F92EE;'>#化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33472, encryptionId=7795334e220, topicName=化合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Sat Jul 07 11:50:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538674, encodeId=07c715386e492, content=<a href='/topic/show?id=59c044154e0' target=_blank style='color:#2F92EE;'>#天然化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44154, encryptionId=59c044154e0, topicName=天然化合物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfa413003642, createdName=TZF0808, createdTime=Fri Aug 25 05:50:00 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236785, encodeId=fc15236e859c, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Aug 24 22:24:54 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236636, encodeId=d34223663661, content=中药单体抗肿瘤又一杰作, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/05/df5ba40a3e218ebaa92f792a589d4bc6.jpg, createdBy=b5081439740, createdName=nkyanglei, createdTime=Thu Aug 24 10:32:51 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236416, encodeId=036623641658, content=已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4ib9DvJ86XtOw5PH8FicmNC2SQbYVgLXBxVWA2A4LlibcSyK7bCJHLVdX00iah2aM0XTEZ7SKtLb3ANw/0, createdBy=006d1709280, createdName=1de9c4fdm02(暂无匿称), createdTime=Wed Aug 23 17:43:48 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236385, encodeId=ae9723638565, content=肾细胞癌治疗又一法宝., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Aug 23 15:54:35 CST 2017, time=2017-08-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1978545, encodeId=82d319e85459b, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Jul 25 06:50:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795450, encodeId=a18e1e9545044, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Oct 07 13:50:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635431, encodeId=827e163543136, content=<a href='/topic/show?id=b099549160a' target=_blank style='color:#2F92EE;'>#抑制作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54916, encryptionId=b099549160a, topicName=抑制作用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd322475383, createdName=124987a0m73(暂无昵称), createdTime=Wed Nov 15 23:50:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906359, encodeId=e0091906359db, content=<a href='/topic/show?id=7795334e220' target=_blank style='color:#2F92EE;'>#化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33472, encryptionId=7795334e220, topicName=化合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Sat Jul 07 11:50:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538674, encodeId=07c715386e492, content=<a href='/topic/show?id=59c044154e0' target=_blank style='color:#2F92EE;'>#天然化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44154, encryptionId=59c044154e0, topicName=天然化合物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfa413003642, createdName=TZF0808, createdTime=Fri Aug 25 05:50:00 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236785, encodeId=fc15236e859c, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Aug 24 22:24:54 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236636, encodeId=d34223663661, content=中药单体抗肿瘤又一杰作, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/05/df5ba40a3e218ebaa92f792a589d4bc6.jpg, createdBy=b5081439740, createdName=nkyanglei, createdTime=Thu Aug 24 10:32:51 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236416, encodeId=036623641658, content=已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4ib9DvJ86XtOw5PH8FicmNC2SQbYVgLXBxVWA2A4LlibcSyK7bCJHLVdX00iah2aM0XTEZ7SKtLb3ANw/0, createdBy=006d1709280, createdName=1de9c4fdm02(暂无匿称), createdTime=Wed Aug 23 17:43:48 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236385, encodeId=ae9723638565, content=肾细胞癌治疗又一法宝., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Aug 23 15:54:35 CST 2017, time=2017-08-23, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1978545, encodeId=82d319e85459b, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Jul 25 06:50:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795450, encodeId=a18e1e9545044, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Oct 07 13:50:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635431, encodeId=827e163543136, content=<a href='/topic/show?id=b099549160a' target=_blank style='color:#2F92EE;'>#抑制作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54916, encryptionId=b099549160a, topicName=抑制作用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd322475383, createdName=124987a0m73(暂无昵称), createdTime=Wed Nov 15 23:50:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906359, encodeId=e0091906359db, content=<a href='/topic/show?id=7795334e220' target=_blank style='color:#2F92EE;'>#化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33472, encryptionId=7795334e220, topicName=化合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Sat Jul 07 11:50:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538674, encodeId=07c715386e492, content=<a href='/topic/show?id=59c044154e0' target=_blank style='color:#2F92EE;'>#天然化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44154, encryptionId=59c044154e0, topicName=天然化合物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfa413003642, createdName=TZF0808, createdTime=Fri Aug 25 05:50:00 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236785, encodeId=fc15236e859c, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Aug 24 22:24:54 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236636, encodeId=d34223663661, content=中药单体抗肿瘤又一杰作, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/05/df5ba40a3e218ebaa92f792a589d4bc6.jpg, createdBy=b5081439740, createdName=nkyanglei, createdTime=Thu Aug 24 10:32:51 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236416, encodeId=036623641658, content=已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4ib9DvJ86XtOw5PH8FicmNC2SQbYVgLXBxVWA2A4LlibcSyK7bCJHLVdX00iah2aM0XTEZ7SKtLb3ANw/0, createdBy=006d1709280, createdName=1de9c4fdm02(暂无匿称), createdTime=Wed Aug 23 17:43:48 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236385, encodeId=ae9723638565, content=肾细胞癌治疗又一法宝., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Aug 23 15:54:35 CST 2017, time=2017-08-23, status=1, ipAttribution=)]
    2017-08-24 1ddf0692m34(暂无匿称)

    学习了.谢谢分享

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1978545, encodeId=82d319e85459b, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Jul 25 06:50:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795450, encodeId=a18e1e9545044, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Oct 07 13:50:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635431, encodeId=827e163543136, content=<a href='/topic/show?id=b099549160a' target=_blank style='color:#2F92EE;'>#抑制作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54916, encryptionId=b099549160a, topicName=抑制作用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd322475383, createdName=124987a0m73(暂无昵称), createdTime=Wed Nov 15 23:50:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906359, encodeId=e0091906359db, content=<a href='/topic/show?id=7795334e220' target=_blank style='color:#2F92EE;'>#化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33472, encryptionId=7795334e220, topicName=化合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Sat Jul 07 11:50:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538674, encodeId=07c715386e492, content=<a href='/topic/show?id=59c044154e0' target=_blank style='color:#2F92EE;'>#天然化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44154, encryptionId=59c044154e0, topicName=天然化合物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfa413003642, createdName=TZF0808, createdTime=Fri Aug 25 05:50:00 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236785, encodeId=fc15236e859c, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Aug 24 22:24:54 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236636, encodeId=d34223663661, content=中药单体抗肿瘤又一杰作, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/05/df5ba40a3e218ebaa92f792a589d4bc6.jpg, createdBy=b5081439740, createdName=nkyanglei, createdTime=Thu Aug 24 10:32:51 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236416, encodeId=036623641658, content=已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4ib9DvJ86XtOw5PH8FicmNC2SQbYVgLXBxVWA2A4LlibcSyK7bCJHLVdX00iah2aM0XTEZ7SKtLb3ANw/0, createdBy=006d1709280, createdName=1de9c4fdm02(暂无匿称), createdTime=Wed Aug 23 17:43:48 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236385, encodeId=ae9723638565, content=肾细胞癌治疗又一法宝., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Aug 23 15:54:35 CST 2017, time=2017-08-23, status=1, ipAttribution=)]
    2017-08-24 nkyanglei

    中药单体抗肿瘤又一杰作

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1978545, encodeId=82d319e85459b, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Jul 25 06:50:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795450, encodeId=a18e1e9545044, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Oct 07 13:50:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635431, encodeId=827e163543136, content=<a href='/topic/show?id=b099549160a' target=_blank style='color:#2F92EE;'>#抑制作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54916, encryptionId=b099549160a, topicName=抑制作用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd322475383, createdName=124987a0m73(暂无昵称), createdTime=Wed Nov 15 23:50:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906359, encodeId=e0091906359db, content=<a href='/topic/show?id=7795334e220' target=_blank style='color:#2F92EE;'>#化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33472, encryptionId=7795334e220, topicName=化合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Sat Jul 07 11:50:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538674, encodeId=07c715386e492, content=<a href='/topic/show?id=59c044154e0' target=_blank style='color:#2F92EE;'>#天然化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44154, encryptionId=59c044154e0, topicName=天然化合物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfa413003642, createdName=TZF0808, createdTime=Fri Aug 25 05:50:00 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236785, encodeId=fc15236e859c, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Aug 24 22:24:54 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236636, encodeId=d34223663661, content=中药单体抗肿瘤又一杰作, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/05/df5ba40a3e218ebaa92f792a589d4bc6.jpg, createdBy=b5081439740, createdName=nkyanglei, createdTime=Thu Aug 24 10:32:51 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236416, encodeId=036623641658, content=已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4ib9DvJ86XtOw5PH8FicmNC2SQbYVgLXBxVWA2A4LlibcSyK7bCJHLVdX00iah2aM0XTEZ7SKtLb3ANw/0, createdBy=006d1709280, createdName=1de9c4fdm02(暂无匿称), createdTime=Wed Aug 23 17:43:48 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236385, encodeId=ae9723638565, content=肾细胞癌治疗又一法宝., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Aug 23 15:54:35 CST 2017, time=2017-08-23, status=1, ipAttribution=)]
    2017-08-23 1de9c4fdm02(暂无匿称)

    已分享

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1978545, encodeId=82d319e85459b, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Jul 25 06:50:00 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795450, encodeId=a18e1e9545044, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sat Oct 07 13:50:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635431, encodeId=827e163543136, content=<a href='/topic/show?id=b099549160a' target=_blank style='color:#2F92EE;'>#抑制作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54916, encryptionId=b099549160a, topicName=抑制作用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cd322475383, createdName=124987a0m73(暂无昵称), createdTime=Wed Nov 15 23:50:00 CST 2017, time=2017-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906359, encodeId=e0091906359db, content=<a href='/topic/show?id=7795334e220' target=_blank style='color:#2F92EE;'>#化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33472, encryptionId=7795334e220, topicName=化合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Sat Jul 07 11:50:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1538674, encodeId=07c715386e492, content=<a href='/topic/show?id=59c044154e0' target=_blank style='color:#2F92EE;'>#天然化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44154, encryptionId=59c044154e0, topicName=天然化合物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfa413003642, createdName=TZF0808, createdTime=Fri Aug 25 05:50:00 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236785, encodeId=fc15236e859c, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Aug 24 22:24:54 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236636, encodeId=d34223663661, content=中药单体抗肿瘤又一杰作, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/05/df5ba40a3e218ebaa92f792a589d4bc6.jpg, createdBy=b5081439740, createdName=nkyanglei, createdTime=Thu Aug 24 10:32:51 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236416, encodeId=036623641658, content=已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4ib9DvJ86XtOw5PH8FicmNC2SQbYVgLXBxVWA2A4LlibcSyK7bCJHLVdX00iah2aM0XTEZ7SKtLb3ANw/0, createdBy=006d1709280, createdName=1de9c4fdm02(暂无匿称), createdTime=Wed Aug 23 17:43:48 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236385, encodeId=ae9723638565, content=肾细胞癌治疗又一法宝., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Aug 23 15:54:35 CST 2017, time=2017-08-23, status=1, ipAttribution=)]
    2017-08-23 1e0f8808m18(暂无匿称)

    肾细胞癌治疗又一法宝.

    0

相关资讯

Sci Rep:长非编码RNA MFI2-AS1的表达是分散局部透明细胞肾细胞癌复发的强烈的预示因子

在透明细胞肾细胞癌(ccRCC)中,复发的预测是辅助治疗开发的一个挑战。在这些肿瘤中,长非编码(lncRNAs)开始表达并且与预后紧密相关。最近,有研究人员进行了旨在利用lncRNA表达来预测ccRCC复发风险的研究。研究人员鉴定了从来自癌症基因组图谱的351例局部ccRCCs中鉴定预后的lncRNAs,并且在167例局部ccRCCs独立群体中验证了基于lncRNA的复发分类。研究人员鉴定出lnc

Lab Invest: 乳突状肾细胞癌趋化素、IL-8和CXCL16可以促进单核细胞募集和分化成泡沫巨噬细胞

乳突状肾细胞癌(pRCC)是肾细胞癌的第二大常见类型。唯一的有效治疗Prcc的方法为根治性外科切除术。如果疾病发生扩散,化疗或者放疗都将不在产生治疗效果,因此对Prcc更进一步的研究非常重要。从组织病理上来说,pRCC是通过乳突的生长模式,即泡沫细胞表型的巨噬细胞焦点聚集。在其他类型的癌症中,在癌症生长和进展时,肿瘤相关的巨噬细胞的清楚的角色已经报道。尽管泡沫状巨噬细胞的出现是pRCC肿瘤的一个组

Sci Rep:较低的平均血小板体积可以预测肾细胞癌不良预后

之前的研究发现,改变的的平均血小板体积(MPV)在几种恶性肿瘤中存在。值得注意的是,MPV在肾细胞癌(RCC)中预后评估的价值还没有达成共识。最近,有研究人员调查了MPV值作为一个RCC预后因子的可能性。该回顾性的研究招募了在2009年1月到2009年12月的306名连续的RCC病人。研究人员对MPV和临床病理学特性的关系进行了分析,并利用卡普兰-梅尔分析方法和Cox回归评估了MPV的预后影响。研

Sci Rep:早期骨骼肌丢失是转移性肾细胞癌的预后生物标记

骨骼肌消耗在患有晚期癌症的病人中是一种常见的现象,并且也许与不良的治疗结果相关。最近,研究人员为了调查是否骨骼肌在患有转移性肾细胞癌(mRCC)且接受靶向治疗病人中的变化与临床结果有关,利用来自许多之前进行的随机临床试验进行了一项观察性群体研究,这些试验在复旦大学上海癌症中心进行。肌肉质量通过比较在治疗开始时和治疗3-4个月后计算机断层扫描图像获得的图像来进行评估。研究总共包括了101名病人。研究

Eur Uro:端粒长度相关的遗传变异与肾细胞癌风险增加有关。

在以往的一些研究中,外周血白细胞的相对端粒长度被认为是肾细胞癌(RCC)风险的潜在生物标志物。为了确定这种关系,研究者进行了更深入的研究。

Eur Urol:纳武单抗治疗晚期肾细胞癌的成本效益。

近年来,一些新的药物作为晚期肾细胞癌(RCC)的二线治疗药出现。在一项CheckMate 025研究中,相比依维莫司,纳武单抗(Nivolumab)提高了整体的生存率以及和治疗相关低毒性。然而,由于其治疗费用高昂,有必要重新考量其疗效和成本关系以评估其真实的价值。